As the first discovered cancer suppressor gene with bispecific phosphatase activity, PTEN has been reported to be able to inhibit the activation of Phosphoinositide 3-kinase (PI3K) and therefore affects the phosphorylation level of its downstream target Akt [10]. This evidence concerns the gene AKT1 and cancer.